SERINC2-YY1 Fusion FISH Probe
The SERINC2-YY1 Fusion FISH Probe is used to confirm a fusion of the SERINC2 and YY1 genes. The fusion of the SERINC2 and YY1 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
SERINC2-YY1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-RERE | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-REOR | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-REGO | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-REGR | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-REAQ | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-ORRE | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-OROR | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-ORGO | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-ORAQ | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-GORE | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-GOOR | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-GOGO | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-GOGR | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-GOAQ | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-GRRE | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-GROR | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-GRGO | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-GRGR | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-GRAQ | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-AQRE | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-AQOR | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-AQGO | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-AQGR | 20 (40 μL) | 200 μL | ||
SERINC2-YY1-20-AQAQ | 20 (40 μL) | 200 μL |
YY1 Gene Summary
YY1 is a ubiquitously distributed transcription factor belonging to the GLI-Kruppel class of zinc finger proteins. The protein is involved in repressing and activating a diverse number of promoters. YY1 may direct histone deacetylases and histone acetyltransferases to a promoter in order to activate or repress the promoter, thus implicating histone modification in the function of YY1. [provided by RefSeq, Jul 2008]
Gene Name: YY1 Transcription Factor
Chromosome: CHR14: 100705101 -100744804
Locus: 14q32.2
SERINC2 Gene Summary
The Serine Incorporator 2 (SERINC2) gene is located on chr1 :31882411-31907527 at 1p35.2.
Gene Name: Serine Incorporator 2
Chromosome: CHR1: 31882411 -31907527
Locus: 1p35.2
Gene Diseases
The SERINC2 YY1 Fusion has been associated with the following diseases:
Disease Name |
---|
Bladder Urothelial Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|